Author:
Hemminki Akseli,Belousova Natalya,Zinn Kurt R.,Liu Bin,Wang Minghui,Chaudhuri Tandra R.,Rogers Buck E.,Buchsbaum Donald J.,Siegal Gene P.,Barnes Mack N.,Gomez-Navarro Jesus,Curiel David T.,Alvarez Ronald D.
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference50 articles.
1. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial;Alvarez;Clin. Cancer Res.,2000
2. Adenoviral-mediated suicide gene therapy for ovarian cancer;Alvarez;Mol. Ther.,2000
3. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer;Hasenburg;Cancer Gene Ther.,2000
4. Multi-dose intraperitoneal Rad/p53 (SCH58500) gene replacement combined with chemotherapy in heavily pretreated recurrent ovarian cancer is associated with prolonged survival;Buller;Proc. Am. Soc. Clin. Oncol.,2001
5. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization;Isner;J. Clin. Invest.,1999
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献